Shopping Cart 0
Cart Subtotal
AED 0

Boehringer Ingelheim GmbH-Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Boehringer Ingelheim GmbH-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs

A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis

An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments

Intelligence on Boehringer Ingelheim GmbH's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Boehringer Ingelheim GmbH's business structure, strategy and prospects.

Key Highlights

Boehringer Ingelheim (BI or 'the group') is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded prescription drugs, consumer health care products, animal health products and biopharmaceuticals. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. BI employed 47,743 people as on December 31, 2014.

READ MORE

Table Of Content

Scope

Company Snapshot

Boehringer Ingelheim GmbH: Company Overview

Boehringer Ingelheim GmbH: Overview and Key Facts

Boehringer Ingelheim GmbH: Overview

Boehringer Ingelheim GmbH: Key Facts

Boehringer Ingelheim GmbH: Key Employees

Boehringer Ingelheim GmbH: Major Products and Services

Boehringer Ingelheim GmbH: Company History

Boehringer Ingelheim GmbH: Management Statement

Boehringer Ingelheim GmbH: Locations and Subsidiaries

Boehringer Ingelheim GmbH: Key Competitors

Boehringer Ingelheim GmbH: Company Analysis

Boehringer Ingelheim GmbH: Business Description

Boehringer Ingelheim GmbH: SWOT Analysis

Boehringer Ingelheim GmbH: SWOT Overview

Boehringer Ingelheim GmbH: Strengths

Boehringer Ingelheim GmbH: Weaknesses

Boehringer Ingelheim GmbH: Opportunities

Boehringer Ingelheim GmbH: Threats

Boehringer Ingelheim GmbH: Corporate Financial Deals Activity

Boehringer Ingelheim GmbH: Financial Deals Overview

Boehringer Ingelheim GmbH: Targets and Partners

Boehringer Ingelheim GmbH: Top Deals 2013-2017YTD*

Boehringer Ingelheim GmbH: Advisors

Boehringer Ingelheim GmbH: Top Financial Advisors

Boehringer Ingelheim GmbH: Partnership

Boehringer Ingelheim GmbH: Divestments

Boehringer Ingelheim GmbH: Recent Developments

Boehringer Ingelheim GmbH: News and Events Summary

Boehringer Ingelheim GmbH: Business Expansion

Boehringer Ingelheim GmbH: Contracts

Boehringer Ingelheim GmbH: Financial Deals

Boehringer Ingelheim GmbH: Regulatory and Legal Events

Boehringer Ingelheim GmbH: Research & Development

Boehringer Ingelheim GmbH: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About Datamonitor


List Of Figure

Figure 1: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Figure 3: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2013-YTD*2017)

Figure 4: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2013-YTD*2017)

Figure 5: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2013-YTD*2017)

Figure 6: Boehringer Ingelheim GmbH: Divestments by Geography (2013-YTD*2017)


List Of Table

Table 1: Boehringer Ingelheim GmbH: Key Facts

Table 2: Boehringer Ingelheim GmbH: Key Employees

Table 4: Boehringer Ingelheim GmbH: Key Competitors

Table 5: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Table 7: Boehringer Ingelheim GmbH: Targets and Partners

Table 8: Boehringer Ingelheim GmbH: Top Deals 2013-2017YTD*

Table 9: Boehringer Ingelheim GmbH: Financial Advisor Ranking by Value (US$m)

Table 10: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2013-YTD*2017)

Table 11: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2013-YTD*2017)

Table 12: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2013-YTD*2017)

Table 13: Boehringer Ingelheim GmbH: Divestments by Geography (2013-YTD*2017)

Table 14: Boehringer Ingelheim GmbH: News and Events Summary

Table 15: Boehringer Ingelheim GmbH: Business Expansion

Table 16: Boehringer Ingelheim GmbH: Contracts

Table 17: Boehringer Ingelheim GmbH: Financial Deals

Table 18: Boehringer Ingelheim GmbH: Regulatory and Legal Events

Table 19: Boehringer Ingelheim GmbH: Research & Development

Table 20: Boehringer Ingelheim GmbH: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Boehringer Ingelheim GmbH

Company Profile

Company Profile Title

Boehringer Ingelheim GmbH-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs

A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis

An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments

Intelligence on Boehringer Ingelheim GmbH's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Boehringer Ingelheim GmbH's business structure, strategy and prospects.

Key Highlights

Boehringer Ingelheim (BI or 'the group') is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded prescription drugs, consumer health care products, animal health products and biopharmaceuticals. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. BI employed 47,743 people as on December 31, 2014.

READ MORE

Scope

Company Snapshot

Boehringer Ingelheim GmbH: Company Overview

Boehringer Ingelheim GmbH: Overview and Key Facts

Boehringer Ingelheim GmbH: Overview

Boehringer Ingelheim GmbH: Key Facts

Boehringer Ingelheim GmbH: Key Employees

Boehringer Ingelheim GmbH: Major Products and Services

Boehringer Ingelheim GmbH: Company History

Boehringer Ingelheim GmbH: Management Statement

Boehringer Ingelheim GmbH: Locations and Subsidiaries

Boehringer Ingelheim GmbH: Key Competitors

Boehringer Ingelheim GmbH: Company Analysis

Boehringer Ingelheim GmbH: Business Description

Boehringer Ingelheim GmbH: SWOT Analysis

Boehringer Ingelheim GmbH: SWOT Overview

Boehringer Ingelheim GmbH: Strengths

Boehringer Ingelheim GmbH: Weaknesses

Boehringer Ingelheim GmbH: Opportunities

Boehringer Ingelheim GmbH: Threats

Boehringer Ingelheim GmbH: Corporate Financial Deals Activity

Boehringer Ingelheim GmbH: Financial Deals Overview

Boehringer Ingelheim GmbH: Targets and Partners

Boehringer Ingelheim GmbH: Top Deals 2013-2017YTD*

Boehringer Ingelheim GmbH: Advisors

Boehringer Ingelheim GmbH: Top Financial Advisors

Boehringer Ingelheim GmbH: Partnership

Boehringer Ingelheim GmbH: Divestments

Boehringer Ingelheim GmbH: Recent Developments

Boehringer Ingelheim GmbH: News and Events Summary

Boehringer Ingelheim GmbH: Business Expansion

Boehringer Ingelheim GmbH: Contracts

Boehringer Ingelheim GmbH: Financial Deals

Boehringer Ingelheim GmbH: Regulatory and Legal Events

Boehringer Ingelheim GmbH: Research & Development

Boehringer Ingelheim GmbH: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About Datamonitor


List Of Figure

Figure 1: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Figure 3: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2013-YTD*2017)

Figure 4: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2013-YTD*2017)

Figure 5: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2013-YTD*2017)

Figure 6: Boehringer Ingelheim GmbH: Divestments by Geography (2013-YTD*2017)


List Of Table

Table 1: Boehringer Ingelheim GmbH: Key Facts

Table 2: Boehringer Ingelheim GmbH: Key Employees

Table 4: Boehringer Ingelheim GmbH: Key Competitors

Table 5: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Boehringer Ingelheim GmbH: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Table 7: Boehringer Ingelheim GmbH: Targets and Partners

Table 8: Boehringer Ingelheim GmbH: Top Deals 2013-2017YTD*

Table 9: Boehringer Ingelheim GmbH: Financial Advisor Ranking by Value (US$m)

Table 10: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2013-YTD*2017)

Table 11: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2013-YTD*2017)

Table 12: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2013-YTD*2017)

Table 13: Boehringer Ingelheim GmbH: Divestments by Geography (2013-YTD*2017)

Table 14: Boehringer Ingelheim GmbH: News and Events Summary

Table 15: Boehringer Ingelheim GmbH: Business Expansion

Table 16: Boehringer Ingelheim GmbH: Contracts

Table 17: Boehringer Ingelheim GmbH: Financial Deals

Table 18: Boehringer Ingelheim GmbH: Regulatory and Legal Events

Table 19: Boehringer Ingelheim GmbH: Research & Development

Table 20: Boehringer Ingelheim GmbH: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Boehringer Ingelheim GmbH